CVS Stock Price - CVS Health Corp. Stock Quote (U.S.: NYSE) - MarketWatch

Open $77.88
Day Range 77.8800 - 80.5850
52 Week Range 69.3000 - 98.6560
Market Cap $78.86B
Shares Outstanding 1.02B
Public Float 1.02B
Beta 0.78
Rev. per Employee $715.3K
P/E Ratio 16.69
EPS $4.80
Yield 2.50%
Dividend $0.50
Ex-Dividend Date Apr 19, 2017
Short Interest 26.36M 06/15/17
% of Float Shorted 2.60%
Average Volume 6.48M

5 Day	3.01%
1 Month	4.36%
3 Month	1.92%
YTD	1.53%
1 Year	-14.49%

MarketWatch
Other Dow Jones

Uber wants Facebook’s Sheryl Sandberg to take the wheel after CEO Travis Kalanick bails out

Jun. 21, 2017 at 2:03 p.m. ET
by MarketWatch

Five reasons you have to buy biotech stocks now

Jun. 20, 2017 at 12:25 p.m. ET
by Michael Brush

Is Amazon serious about getting into pharmacy? This analyst isn’t so sure

Jun. 20, 2017 at 12:10 p.m. ET
by Emma Court

Amazon’s Whole Foods deal pummels pharmaceutical stocks

Jun. 16, 2017 at 3:03 p.m. ET
by Emma Court

Are low-volatility stocks in a bubble?

May. 16, 2017 at 4:48 p.m. ET
by Mark Hulbert

Mylan’s EpiPen sales have taken a hit

May. 10, 2017 at 11:46 a.m. ET
by MarketWatch

Here’s the ‘last remaining cheap asset’ as the Fed pumps up prices for everything else

May. 2, 2017 at 9:16 a.m. ET
by Victor Reklaitis

CVS profit falls on soft traffic to stores

CVS Health Corp. reported lower profit in the first quarter of what its chief executive has called a "rebuilding year," as fewer customers visited its stores and it was pressured by more generic drugs.

May. 2, 2017 at 8:03 a.m. ET
by MarketWatch.com

CVS earnings beat estimates

CVS Health Corp. reported first-quarter net income of $953.0 million, or 92 cents per share, down from $1.15 billion, or $1.04 per share, for the same period last year. Adjusted EPS was $1.17, beating the $1.10 FactSet consensus. Revenue was $44.5 billion, up from $43.2 billion, and ahead of the $44.2 billion FactSet consensus. Revenue in pharmacy services was up 8.5% to $31.2 billion driven by claim volume, brand inflation and growth in specialty pharmacy. Pharmacy same-store sales fell 4.7%, impacted by about 480 basis points due to generic introductions and about 460 basis points by previously-discussed marketplace changes. Retail revenue was down 3.8% to $19.3 billion, driven largely by a 4.7% decline in same-store sales, reimbursement pressure and an increase in generic reimbursement rate. CVS confirmed its full-year EPS guidance of $5.02 to $5.18 and adjusted EPS of $5.77 to $5.93. It introduced second-quarter guidance of EPS of $1.15 to $1.19 and adjusted EPS of $1.29 to $1.33. CVS shares slipped 0.4% in Tuesday premarket trading and are down 19.2% for the past year. The S&P 500 index is up 14.7% for the last 12 months.

May. 2, 2017 at 7:14 a.m. ET
by Tonya Garcia

CVS Health sees Q2 adj. EPS $1.29-$1.33; FactSet consensus $1.33

May. 2, 2017 at 7:00 a.m. ET
by Tomi Kilgore

CVS Health affirmed 2017 adj. EPS outlook $5.77-$5.93; FactSet consensus $5.86

May. 2, 2017 at 7:00 a.m. ET
by Tomi Kilgore

CVS Health Q1 front-end same-store sales down 4.9%; FactSet consensus down 6.1%

May. 2, 2017 at 6:59 a.m. ET
by Tomi Kilgore

CVS Health Q1 pharmacy same-store sales declined 4.7%; FactSet consensus down 4.2%

May. 2, 2017 at 6:59 a.m. ET
by Tomi Kilgore

CVS Health Q1 revenue $44.51 bln vs. $43.22 bln; FactSet consensus $44.20 bln

May. 2, 2017 at 6:58 a.m. ET
by Tomi Kilgore

CVS Health Q1 adj. EPS $1.17; FactSet consensus $1.10

May. 2, 2017 at 6:58 a.m. ET
by Tomi Kilgore

CVS Health Q1 EPS 92 cents vs. $1.04 a year ago

May. 2, 2017 at 6:57 a.m. ET
by Tomi Kilgore

Amazon’s next customer: Americans who don’t have a bank account

Apr. 27, 2017 at 4:10 p.m. ET
by Maria LaMagna

Express Scripts stock surges on investor hopes for an Anthem reconciliation

Apr. 27, 2017 at 7:19 a.m. ET
by Emma Court

Everyone loves these stocks — that’s why you should avoid them

Apr. 26, 2017 at 3:46 a.m. ET
by Michael Brush

Express Scripts is airing dirty laundry in its nasty, very public Anthem divorce

Apr. 25, 2017 at 4:23 p.m. ET
by Emma Court

How Amazon Made Some Shorts a Lot of Money

A plunge in shares of grocers and other retailers netted short sellers a lot of money after Amazon.com Inc. announced a deal to buy Whole Foods Market Inc. on Friday.

Jun. 20, 2017 at 3:06 p.m. ET
on The Wall Street Journal

Could Amazon Get Into the Pharmacy Game Next?

Pharmacy chains now face 'an additional level of urgency' after Amazon agreed to buy Whole Foods, one analyst said.

Jun. 19, 2017 at 3:57 p.m. ET
on The Wall Street Journal

When Cholesterol Drugs Cost $14,000, an Insurance Tug-of-War

Patients struggle to obtain PCSK9 inhibitors, a powerful class of drugs that lower bad cholesterol in difficult cases and when usual treatments and statins don’t work.

Jun. 19, 2017 at 2:53 p.m. ET
on The Wall Street Journal

Apprenticeships Aren’t Just for Welders Anymore

A small but growing number of young people are now apprenticing in fields that require a suit and tie instead of coveralls and gloves, with firms ranging from Wells Fargo to Aon embracing apprenticeship-style programs.

Jun. 14, 2017 at 6:18 p.m. ET
on The Wall Street Journal

Mid-Year Roundtable: 26 Investment Picks

The market could get bumpy, but Disney and Dollar Tree could shine. What Gabelli and Gundlach like now.

Jun. 10, 2017 at 12:01 a.m. ET
on Barron's Online

Why It Would be Tough for Amazon to Beat CVS and Walgreens

The online behemoth is reportedly considering selling pharmaceuticals, but one analyst explains why it’s a tough industry to disrupt.

May. 17, 2017 at 2:22 p.m. ET
on Barron's Online

Why Your Pharmacy May Be Texting You

Stephen J. Gold, CIO of CVS, says its customer data is crucial to improving patient health.

May. 16, 2017 at 10:09 p.m. ET
on The Wall Street Journal

Tracking Amazon’s Rise to Retail Stock Dominance

Amazon went public at a time when shares of department stores Sears, Roebuck & Co., J.C. Penney Inc. and Macy’s operator Federated Department Stores Inc. were among the biggest retail stocks in the U.S. Twenty years later, none of these department stores remain on the list of the largest U.S. retail stocks.

May. 15, 2017 at 1:57 p.m. ET
on The Wall Street Journal

Costco’s Special Payout Comes With Trade-Offs

The chain keeps its regular dividends low, but supplements them with special payouts.

May. 6, 2017 at 12:32 a.m. ET
on Barron's Online

Novo Nordisk Struggles to Raise Prices

A weakening British pound presents a two-fold challenge for Novo Nordisk A/S, the Danish insulin producer.

May. 3, 2017 at 5:34 p.m. ET
on The Wall Street Journal

Stocks to Watch: Aetna, Pfizer, Apple

Among the companies with shares expected to trade actively in Tuesday's session are Aetna Inc., Pfizer Inc. and Apple Inc.

May. 2, 2017 at 9:18 a.m. ET
on The Wall Street Journal

CVS Profit Declines in First Quarter of ‘Rebuilding Year’

CVS reported lower profit in the first quarter of what its chief executive has called a “rebuilding year,” as fewer customers visited its stores and it was pressured by more generic drugs.

May. 2, 2017 at 8:02 a.m. ET
on The Wall Street Journal

Big-Name Food Brands Lose Battle of the Grocery Aisle

America’s packaged-food giants are losing the battle for retailers’ shelf space, complicating their efforts to break out of a yearslong slump.

Apr. 30, 2017 at 10:10 p.m. ET
on The Wall Street Journal

Banks, Restaurants, MLPs Could Win Under Tax Plan

Lower tax rates would be a boon for companies such as JPMorgan Chase, Berkshire Hathaway, and Anthem.

Apr. 29, 2017 at 12:01 a.m. ET
on Barron's Online

No Easy Remedy for Express Scripts Stock

Nasty battle with client Anthem over payments hints at broader health-care battles for pharmacy-benefits manager.

Apr. 29, 2017 at 12:06 a.m. ET
on Barron's Online

The 10-Point: Gerard Baker on Trump’s First 100 Days, a No. 2 for Uber, Purdue University’s Push Into Online Education and More

A personal, guided tour to the best scoops and stories every day in The Wall Street Journal, from Editor in Chief Gerard Baker.

Apr. 28, 2017 at 7:10 a.m. ET
on The Wall Street Journal

Uber Interviews Heavyweights for a Crucial Job: Handling Travis Kalanick

The ride-sharing giant has approached current or former officials from companies including Disney, Wal-Mart and CVS in a bid to revamp operations and bring discipline to its culture.

Apr. 27, 2017 at 7:23 p.m. ET
on The Wall Street Journal

Express Scripts Faces a Future Without Its Biggest Customer

Express Scripts Holdings, the largest administrator of prescription-drug benefits in the U.S., is facing an identity crisis as it grapples with replacing $17.1 billion in annual revenue following the loss of its biggest customer, health-insurer Anthem.

Apr. 25, 2017 at 6:50 p.m. ET
on The Wall Street Journal

CVS Move Hurts Hershey, Boosts Post, Mondelez

The retailer is accelerating plans to increase floor space for nutritious foods at the expense of confectionery.

Apr. 25, 2017 at 5:50 p.m. ET
on Barron's Online

Corporate Feud Exposes Big Profits on Drug Sales

A dispute between the largest pharmacy benefit manager and a health insurance giant has shown how profitable some relationships have become—giving more ammunition to critics of the health-care system.

Apr. 25, 2017 at 10:50 a.m. ET
on The Wall Street Journal

Other News
Press Releases

Smart Beta Dividend Growth Stocks

Jun. 26, 2017 at 9:09 p.m. ET
on Seeking Alpha

Here's Why Diplomat Pharmacy Inc. Shares Are Down as Much as 13%

Jun. 26, 2017 at 6:30 p.m. ET
on Motley Fool

Rite Aid Leaps On Report That Walgreens Deal Is Nearing FTC OK

Reports indicate that the drawn-out Rite Aid (RAD)-Walgreens Boots Alliance (WBA) merger may be edging toward fruition, sending Rite Aid shares soaring Monday. [ibd-display-video id=1175457 width=50 float =left] The pop in price has been linked to a CTFN article that reportedly cites antitrust lawyers and a former DOJ official, according to Seeking Alpha. The CTFN story is behind a paywall, but StreetInsider quotes the article as saying that

Jun. 26, 2017 at 12:39 p.m. ET
on Investors Business Daily

CVS Option Alert: Fri $80 Puts Sweep (19) at the Ask: 853 @ $0.638 vs 112 OI; Ref=$80.31

Jun. 26, 2017 at 12:07 p.m. ET
on benzinga.com

CVS Option Alert: Jul 21 $81 Calls Sweep (19) at the Ask: 500 @ $1.27 vs 219 OI; Ref=$80.54

Jun. 26, 2017 at 11:50 a.m. ET
on benzinga.com

Sifting Through The Retail Wreck

Jun. 26, 2017 at 12:01 p.m. ET
on Seeking Alpha

3 Nagging Challenges for Realty Income Corp (O) Stock

Jun. 26, 2017 at 11:22 a.m. ET
on InvestorPlace.com

Wall Street Sees a 22% Upside in Walgreens

Walgreens is covered by 25 Wall Street analysts. The company has received a rating of 2 on a scale of 1 (strong buy) to 5 (sell). It has 72% "buy" and 28% "hold" recommendations and no "sell" recommendations.

Jun. 23, 2017 at 2:04 p.m. ET
on MarketRealist.com

Comparing Walgreens’s Stock Market Performance with Its Peers’

Walgreens Boots Alliance (WBA) was trading at $76.37 as of June 22, 2017, near its 52-week low of $76.26. The company has fallen 7.7% YTD (year-to-date).

Jun. 23, 2017 at 2:04 p.m. ET
on MarketRealist.com

After 20 Months, Still No Walgreens–Rite Aid Deal Approval

Walgreens Boots Alliance’s (WBA) proposed acquisition of Rite Aid (RAD) continues to await FTC (Federal Trade Commission) approval 20 months after the deal's announcement.

Jun. 23, 2017 at 2:04 p.m. ET
on MarketRealist.com

3 Dividend Stocks for Smart Investors

Jun. 25, 2017 at 11:12 a.m. ET
on Motley Fool

Where Will Walgreens’ Earnings Head in Fiscal 3Q17?

Walgreens Boots Alliance’s (WBA) fiscal 3Q17 earnings per share (or EPS) are expected to rise 10.2% YoY (year-over-year) to $1.30.

Jun. 23, 2017 at 2:04 p.m. ET
on MarketRealist.com

Discussing Walgreens’s Top Line ahead of Its Fiscal 3Q17 Results

Walgreens Boots Alliance (WBA) will be reporting its fiscal 3Q17 results on June 29, 2017. The company is expected to report a 0.8% YoY (year-over-year) rise in its total sales.

Jun. 23, 2017 at 2:04 p.m. ET
on MarketRealist.com

The MnM Portfolio, June 2017 Supplement - How Amazon-Proof Is The Portfolio?

Jun. 23, 2017 at 2:52 p.m. ET
on Seeking Alpha

Will Walgreens Continue Its Hit-and-Miss Saga in Fiscal 3Q17?

Walgreens Boots Alliance is scheduled to release its fiscal 3Q17 results on June 29, 2017. The pharmacy giant is expected to report a 10.2% year-over-year rise in its earnings per share.

Jun. 23, 2017 at 2:04 p.m. ET
on MarketRealist.com

How Amazon’s Latest Acquisition Could Affect the Drugstore Space

In this article, we'll discuss how Amazon’s latest bid to acquire Whole Foods Market has affected the drugstore sector and what it means for the industry going forward.

Jun. 23, 2017 at 2:04 p.m. ET
on MarketRealist.com

Why CVS Health Corp (CVS) Stock Will Win BIG With Trumpcare

Jun. 23, 2017 at 12:13 p.m. ET
on InvestorPlace.com

Is Patience Still a Virtue With Rite Aid Corporation (RAD) Stock?

Jun. 23, 2017 at 7:30 a.m. ET
on InvestorPlace.com

Breaking Up Amazon.com Is Plain Old Silly-Talk

Jun. 23, 2017 at 8:01 a.m. ET
on Motley Fool

Amazon Purchases Whole Foods: The Global Context

Jun. 23, 2017 at 7:29 a.m. ET
on Seeking Alpha

S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017

Jun. 21, 2017 at 10:00 a.m. ET
on PR Newswire - PRF

Points of Light Recognizes CVS Health As One Of The 50 Most Community-Minded Companies In The United States

Jun. 21, 2017 at 8:30 a.m. ET
on PR Newswire - PRF

Today's Research Reports on Stocks to Watch: CVS Health and Walgreens Boots Alliance

Jun. 19, 2017 at 8:04 a.m. ET
on ACCESSWIRE

CVS Health Joins Drug Store News and Mack Elevation in Convening Health Innovation Summit

Jun. 13, 2017 at 9:14 a.m. ET
on PR Newswire - PRF

Cigna and CVS Health Launch Cigna Health Works, A New Model for Customer-Enabled Design for Affordable, Convenient Access to Pharmacy and Health Care

Jun. 8, 2017 at 10:00 a.m. ET
on BusinessWire - BZX

Cigna and CVS Health Launch Cigna Health Works, A New Model for Customer-Enabled Design for Affordable, Convenient Access to Pharmacy and Health Care

Jun. 8, 2017 at 10:00 a.m. ET
on PR Newswire - PRF

CVS Pharmacy Now Using Time Delay Safes in Ohio for Controlled Substances to Combat Opioid Epidemic, Reduce Robbery Incidents

Jun. 7, 2017 at 11:15 a.m. ET
on PR Newswire - PRF

CVS Pharmacy Opens First Retail Location in Colorado

May. 30, 2017 at 3:44 p.m. ET
on PR Newswire - PRF

Attorney General Brnovich, Rep. Carter Join CVS Health to Announce Availability of Naloxone at All CVS Pharmacy Locations in Arizona

May. 23, 2017 at 1:00 p.m. ET
on PR Newswire - PRF

Healthcare Stocks on Investors' Radar -- CVS Health, Express Scripts, Aetna, and Cigna

May. 16, 2017 at 7:05 a.m. ET
on PR Newswire - PRF

CVS Pharmacy Launches Long Live Skin Campaign to Increase Awareness Around Sun Safety and Skin Health

May. 15, 2017 at 8:30 a.m. ET
on PR Newswire - PRF

Post Earnings Coverage as CVS Outperformed Top- and Bottom-Line Expectations

May. 15, 2017 at 8:19 a.m. ET
on ACCESSWIRE

CVS Health To Present At The UBS Global Healthcare Conference

May. 12, 2017 at 12:00 p.m. ET
on PR Newswire - PRF

CVS Health Stockholders Elect Former SEC Chairman Mary L. Schapiro as New Director at Annual Meeting

May. 10, 2017 at 10:17 a.m. ET
on PR Newswire - PRF

CVS Health Corporate Social Responsibility Activities Address Important National and Local Health Care Issues and Contribute to Economic Growth

May. 10, 2017 at 9:00 a.m. ET
on PR Newswire - PRF

CVS Health Offering Hepatitis A Vaccine to Hawaii Residents Following Recall of Contaminated Fish

May. 3, 2017 at 10:38 p.m. ET
on PR Newswire - PRF

Covered Call reports for Coach, CVS Health Corp, The Kroger Co, NVIDIA and Sprint Corp include trade ideas that offer returns of 18% or more!

May. 3, 2017 at 9:31 a.m. ET
on PR Newswire - PRF

DiversityInc® Recognizes CVS Health on List of "Top 50 Companies for Diversity"

May. 3, 2017 at 8:00 a.m. ET
on PR Newswire - PRF

CVS Health Lauds New Research Showing that Limiting Pharmaceutical Detailing Can Impact Prescribing Behavior

May. 2, 2017 at 11:05 a.m. ET
on PR Newswire - PRF

CVS Health Reports First Quarter Results; Confirms 2017 EPS Guidance

May. 2, 2017 at 6:55 a.m. ET
on PR Newswire - PRF

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI. (See Full Profile)

Sell
Under
Hold
Over
Buy

Number of Ratings 24 Full Ratings

Wall Street Sees a 22% Upside in Walgreens

Jun. 23, 2017 at 2:04 p.m. ET
on MarketRealist.com

Amazon In The Pharmacy Space: Is There Anything To This Beyond The Headlines?

May. 18, 2017 at 3:09 p.m. ET
on Benzinga.com

Benzinga's Top Upgrades, Downgrades For April 28, 2017

Apr. 28, 2017 at 9:17 a.m. ET
on Benzinga.com

Name	Chg %	Market Cap
PetMed Express Inc.	-0.25%	$830.69M
BioScrip Inc.	3.36%	$324.23M
Rite Aid Corp.	30.23%	$3.28B
PharMerica Corp.	0.19%	$811.58M
Walgreens Boots Alliance Inc.	1.56%	$82.52B

Competitor Data Provided By

Asia Dow	3,356.65	-0.36	-0.01%
Nikkei 225	20,213.62	60.27	0.30%
Hang Seng	25,890.38	18.49	0.07%
Shanghai	3,181.63	-3.82	-0.12%
Sensex	31,138.21	-152.53	-0.49%
Singapore	3,223.09	13.62	0.42%

CVS Health Corp.

$ 80.12

Customize MarketWatch

No Items in Watchlist

No Saved Watchlists

Uh oh

No Recent Tickers

CVS Health sees Q2 adj. EPS $1.29-$1.33; FactSet consensus $1.33

CVS Health affirmed 2017 adj. EPS outlook $5.77-$5.93; FactSet consensus $5.86

CVS Health Q1 front-end same-store sales down 4.9%; FactSet consensus down 6.1%

CVS Health Q1 pharmacy same-store sales declined 4.7%; FactSet consensus down 4.2%

CVS Health Q1 revenue $44.51 bln vs. $43.22 bln; FactSet consensus $44.20 bln

CVS Health Q1 adj. EPS $1.17; FactSet consensus $1.10

CVS Health Q1 EPS 92 cents vs. $1.04 a year ago

Stocks

Columns

Authors

Topics

^$ 80.12